Welcome to the official website of BioCoreUSA Corp!
EN
              home > TISSUE ARRAYS > Stomach > DST1101
              • Cores:
                110
                CASES:
                110
                Core Diameter(mm):
                1
                Thickness(µm):
                5
                Row number:
                11
                Column number:
                10
                Tissue Array Type:
                FFPE
                Species:
                Human
              DST1101
              $255.00
              Add To Collect

              Description: Stomach cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 110 cases/110 cores

              Details: Stomach adenocarcinoma tissue microarray with adjacent normal tissue, containing 100 cases of adenocarcinoma, 5 adjacent normal stomach tissue, single core per case

              Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

              Please Select Tissue Array Type:
              Tag:
              110 Cores110 CasesStomach Matched or Unmatched special price single core per case
              Add To Cart
              Outright purchase
              Note

              1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
              2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
              In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

              • Specification sheet
              • Overlapping case
              • Download specifications
              Legend:
              Car-Cardia Eso-Fsophagus
              • NAT(*)
              • Malignant(IB)
              • Malignant(IIA)
              • Malignant(IIB)
              • Malignant(IIIA)
              • Malignant(IIIB)
              • Malignant(IIIC)
              • _ma
              TISSUE ARRAYS
              DST1101
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              A
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              B
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              C
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              D
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              E
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              F
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              G
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              H
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              I
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              J
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              K
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              Sto
              _ma
              DST1101
              • Age:
              • Sex:
              • Organ/Anatomic Site:
              • Pathology diagnosis:
              • Grade:
              • TNM:
              • Stage:
              • Tissue ID.:
              • Type:
              Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size Ki-67 CK18
              A1
              		 1 30 F Stomach Adenocarcinoma with necrosis 1 T3N3aM0 IIIB Malignant * - ++,80%
              A2
              		 2 52 M Stomach Adenocarcinoma (sparse) 1 T3N1M0 IIB Malignant 5*4.5*0.7 - +++,100%
              A3
              		 3 59 M Stomach Adenocarcinoma (sparse) 1 T3N0M0 IIA Malignant 4.0*4.0*0.5 - ++,80%
              A4
              		 4 73 M Stomach Mucinous adenocarcinoma (sparse) 1 T4bN2M0 IIIB Malignant 18*15*1 - ++,90%
              A5
              		 5 60 M Stomach Adenocarcinoma 1--2 T2N0M0 IB Malignant 4.0*3.0*0.5 * *
              A6
              		 6 68 F Stomach Adenocarcinoma 1--2 T3N3aM0 IIIB Malignant 16*5*3.5 +,5% +++,100%
              A7
              		 7 64 M Stomach Adenocarcinoma 2 T3N0M0 IIA Malignant 4.5*4.5*0.5 - ++,90%
              A8
              		 8 57 M Stomach Adenocarcinoma 2 T3N3bM0 IIIC Malignant 4.5*4.0*0.5 +,10% ++,100%
              A9
              		 9 62 M Stomach Adenocarcinoma 2 T3N2M0 IIIA Malignant 5.0*3.5*0.5 +,20% +,70%
              A10
              		 10 37 F Stomach Adenocarcinoma 2 T3N3aM0 IIIB Malignant 5.0*3.5*0.5 +,15% ++,90%
              B1
              		 11 61 F Stomach Adenocarcinoma 2 T3N1M0 IIB Malignant 8*8 +,30% +,90%
              B2
              		 12 61 F Stomach Adenocarcinoma 2 T4aN0M0 IIB Malignant 12*8*6 +,3% ++,90%
              B3
              		 13 44 F Stomach Adenocarcinoma 2 T3N2M0 IIIA Malignant * +,5% ++,100%
              B4
              		 14 66 M Stomach Adenocarcinoma 2 T3N2M0 IIIA Malignant * +,15% ++,80%
              B5
              		 15 48 M Stomach Adenocarcinoma 2 T3N2M0 IIIA Malignant 10*6.5*4.5 +,20% ++,90%
              B6
              		 16 57 M Stomach Adenocarcinoma (sparse) 2 T3N2M0 IIIA Malignant 8*6*4.5 +,5% ++,40%
              B7
              		 17 58 M Stomach Adenocarcinoma 2 T3N0M0 IIA Malignant 18*12*7 - +,20%
              B8
              		 18 65 M Stomach Adenocarcinoma 2 T3N1M0 IIB Malignant * +,30% ++,90%
              B9
              		 19 56 F Stomach Adenocarcinoma with necrosis 2 T3N0M0 IIA Malignant * - +++,80%
              B10
              		 20 45 M Stomach Adenocarcinoma 2 T3N1M0 IIB Malignant 5.0*4.0*0.5 +,15% +++,80%
              C1
              		 21 61 M Stomach Adenocarcinoma 2 T3N0M0 IIA Malignant 5.5*3.0*0.5 +,10% ++,90%
              C2
              		 22 32 M Stomach Adenocarcinoma 2 T3N2M0 IIIA Malignant 6.0*5.0*1.0 +,25% ++,80%
              C3
              		 23 56 F Stomach Adenocarcinoma 2 T3N2M0 IIIA Malignant 5.5*4.5*0.5 +,30% ++,100%
              C4
              		 24 62 M Stomach Adenocarcinoma 2 T4aN2M0 IIIB Malignant 5*3*1 +,35% ++,90%
              C5
              		 25 52 M Stomach Adenocarcinoma 2 T3N1M0 IIB Malignant 6*5*1.8 +,2% ++,90%
              C6
              		 26 75 M Stomach Adenocarcinoma 2 T4aN1M0 IIIA Malignant 6*5*1.5 +,25% +,70%
              C7
              		 27 59 M Stomach Adenocarcinoma 2 T3N0M0 IIA Malignant 3.5*3.0*0.5 +,15% ++,80%
              C8
              		 28 62 M Stomach Mucinous adenocarcinoma 2 T3N0M0 IIA Malignant 8*3*3 - +++,100%
              C9
              		 29 60 M Stomach Adenocarcinoma 2--3 T3N2M0 IIIA Malignant 4*3.5*0.5 +,35% ++,80%
              C10
              		 30 47 M Stomach Adenocarcinoma 2--3 T3N3bM0 IIIC Malignant 5.0*3.5*0.5 +,30% +++,90%
              D1
              		 31 42 M Stomach Adenocarcinoma with necrosis 2--3 T4aN3aM0 IIIB Malignant 6.0*5.5*0.5 +,30% ++,90%
              D2
              		 32 41 M Stomach Adenocarcinoma 2--3 T3N0M0 IIA Malignant * - ++,60%
              D3
              		 33 52 F Stomach Adenocarcinoma 2--3 T3N0M0 IIA Malignant * +,35% ++,60%
              D4
              		 34 62 M Stomach Adenocarcinoma 2--3 T3N2M0 IIIA Malignant 6.5*5.0*0.5 +,5% ++,100%
              D5
              		 35 52 F Stomach Adenocarcinoma 2--3 T4bN0M0 IIIA Malignant 5.0*5.0*0.5 +,10% ++,100%
              D6
              		 36 47 M Stomach Adenocarcinoma 2--3 T3N0M0 IIA Malignant 6.0*5.0*1.0 +,40% ++,90%
              D7
              		 37 41 F Stomach Adenocarcinoma 2--3 T4aN2M0 IIIA Malignant 3.5*1.5*0.5 +,5% +++,90%
              D8
              		 38 65 M Stomach Adenocarcinoma 2--3 T3N0M0 IIA Malignant 8.0*6.0*1.0 +,10% +++,90%
              D9
              		 39 49 F Stomach Adenocarcinoma 2--3 T3N3aM0 IIIB Malignant 4.0*3.5*0.5 +,10% ++,90%
              D10
              		 40 41 F Stomach Adenocarcinoma 2--3 T3N0M0 IIA Malignant * +++,80% ++,50%
              E1
              		 41 68 M Stomach Adenocarcinoma 2--3 T3N3aM0 IIIB Malignant 8*8 +,20% +,20%
              E2
              		 42 52 F Stomach Adenocarcinoma 2--3 T4aN2M0 IIIA Malignant 3*2cm +,20% ++,80%
              E3
              		 43 67 M Stomach Adenocarcinoma 2--3 T3N2M0 IIIA Malignant 6.0*4.0*0.5 +,5% ++,90%
              E4
              		 44 67 M Stomach Adenocarcinoma 2--3 T4aN0M0 IIB Malignant 4.5*4.5*1 +,5% ++,90%
              E5
              		 45 67 F Stomach Adenocarcinoma 2--3 T3N0M0 IIA Malignant 4.5*4.0*0.8 +,15% ++,90%
              E6
              		 46 48 M Stomach Adenocarcinoma 2--3 T4aN3M0 IIIC Malignant 4.5*3.5*0.6 +,3% +,70%
              E7
              		 47 42 M Stomach Adenocarcinoma (interstitial) * T3N0M0 IIA Malignant * +,10% -
              E8
              		 48 63 F Stomach Adenocarcinoma 2--3 T3N1M0 IIB Malignant 5.0*3.5*0.5 +,30% +++,100%
              E9
              		 49 59 M Stomach Mucinous adenocarcinoma 2--3 T3N1M0 IIB Malignant * +,30% ++,90%
              E10
              		 50 53 M Stomach Adenocarcinoma 3 T3N2M0 IIIA Malignant * +,30% +++,90%
              F1
              		 51 40 M Stomach Adenocarcinoma 3 T3N2M0 IIIA Malignant 5.0*5.0*0.5 +,10% +,20%
              F2
              		 52 58 M Stomach Adenocarcinoma 3 T3N3aM0 IIIB Malignant * +,5% ++,60%
              F3
              		 53 41 M Stomach Adenocarcinoma 3 T3N3aM0 IIIB Malignant 3.5*3.0*0.5 +,3% ++,100%
              F4
              		 54 68 F Stomach Adenocarcinoma 3 T4bN2M0 IIIB Malignant 7*6*4 - ++,100%
              F5
              		 55 48 M Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 4.0*3.0*0.5 +,5% ++,90%
              F6
              		 56 38 M Stomach Adenocarcinoma (sparse) 3 T3N0M0 IIA Malignant 3.0*2.5*0.5 +,6% ++,90%
              F7
              		 57 60 M Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 4.5*3*1.0 * +,70%
              F8
              		 58 40 M Stomach Adenocarcinoma (sparse) 3 T3N2M0 IIIA Malignant 2*2*0.5 +,2% +,10%
              F9
              		 59 53 M Stomach Adenocarcinoma 3 T4aN0M0 IIB Malignant 5*3.5*1.0 +,30% ++,90%
              F10
              		 60 44 F Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 4.0*3.5*0.5 +,10% ++,90%
              G1
              		 61 73 M Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 6*3.8*0.5 - ++,80%
              G2
              		 62 54 M Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant * ++,55% ++,90%
              G3
              		 63 41 F Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 3.5*1.5*0.5 - ++,70%
              G4
              		 64 73 M Stomach Adenocarcinoma 3 T3N3M0 IIIB Malignant 12*11.5*3 - ++,90%
              G5
              		 65 61 M Stomach Adenocarcinoma 3 T3N1M0 IIB Malignant * +,10% +,10%
              G6
              		 66 72 M Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 6.0*4.5*0.5 ++,25% ++,90%
              G7
              		 67 48 M Stomach Adenocarcinoma 3 T3N2M0 IIIA Malignant 8*4.5*4.0 +,10% ++,90%
              G8
              		 68 40 F Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 11*9*5 - ++,90%
              G9
              		 69 60 M Stomach Adenocarcinoma 3 T3N3aM0 IIIB Malignant 6.0*4.5*0.5 - ++,70%
              G10
              		 70 55 M Stomach Adenocarcinoma (sparse) 3 T3N2M0 IIIA Malignant * - +,5%
              H1
              		 71 50 M Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 6.5*4.5*0.5 +,2% +,80%
              H2
              		 72 59 M Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 5*3.5*1.0 +,10% ++,90%
              H3
              		 73 55 F Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 12*4.5*4.0 +,5% +,90%
              H4
              		 74 42 M Stomach Adenocarcinoma 3 T3N2M0 IIIA Malignant 8.0*7.0*0.5*1.0 +,6% +,40%
              H5
              		 75 48 M Stomach Adenocarcinoma 3 T3N3aM0 IIIB Malignant * +,25% +++,100%
              H6
              		 76 53 F Stomach Adenocarcinoma 3 T4bN3bM0 IIIC Malignant 6.5*5.5*0.5 +,5% ++,80%
              H7
              		 77 68 M Stomach Adenocarcinoma 3 T3N3aM0 IIIB Malignant * ++,35% ++,90%
              H8
              		 78 40 M Stomach Adenocarcinoma 3 T3N2M0 IIIA Malignant * +,15% ++,90%
              H9
              		 79 32 F Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 14*8*5 - ++,90%
              H10
              		 80 53 M Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 5.5*4.5*0.5 +,25% ++,80%
              I1
              		 81 51 M Stomach Adenocarcinoma 3 T3N3aM0 IIIB Malignant * - +,70%
              I2
              		 82 60 M Stomach Adenocarcinoma 3 T3N3aM0 IIIB Malignant 8*6.5*4.0 +,10% ++,80%
              I3
              		 83 68 M Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 4.5*3.5*0.6 +,10% +,70%
              I4
              		 84 61 M Stomach Adenocarcinoma 3 T3N1M0 IIIB Malignant 5*5*1 - -
              I5
              		 85 54 F Stomach Adenocarcinoma 3 T3N1M0 IIB Malignant 8*8*4.5 +,5% +++,100%
              I6
              		 86 60 M Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant * ++,60% +++,100%
              I7
              		 87 57 M Stomach Adenocarcinoma 3 T3N2M0 IIIA Malignant * +,5% ++,80%
              I8
              		 88 47 M Stomach Adenocarcinoma 3 T3N3aM0 IIIB Malignant 5.0*5.0*0.5 - +,50%
              I9
              		 89 58 M Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 7.0*6.0*1.0 +,10% ++,70%
              I10
              		 90 52 M Stomach Adenocarcinoma 3 T3N3aM0 IIIB Malignant * +,20% +++,100%
              J1
              		 91 48 F Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant * +,2% ++,90%
              J2
              		 92 63 M Stomach Adenocarcinoma 3 T2N0M0 IB Malignant 5.5*4.5*1.1 ++,20% ++,90%
              J3
              		 93 61 F Stomach Adenocarcinoma 3 T3N0M0 IIA Malignant 5.0*4.5*0.5 +,6% ++,80%
              J4
              		 94 72 M Stomach Mucinous adenocarcinoma 3 T3N2M0 IIIA Malignant 7.0*4.5*1.0 +,8% ++,85%
              J5
              		 95 66 F Stomach Mucinous adenocarcinoma 3 T3N3aM0 IIIB Malignant * +,20% +,20%
              J6
              		 96 42 F Stomach Mucinous adenocarcinoma 3 T3N2M0 IIIA Malignant 3.5*3.0*0.5 +,5% ++,80%
              J7
              		 97 45 M Stomach Adenocarcinoma (sparse) 3--4 T3N3aM0 IIIB Malignant 8*6.5*4.0 +,2% ++,80%
              J8
              		 98 68 M Stomach Adenocarcinoma 3 T4aN2M0 IIIB Malignant 10*6*2.5 +,80% +++,90%
              J9
              		 99 40 F Stomach Mucinous adenocarcinoma * T3N3aM0 IIIB Malignant 5*3.5*1.0 +,10% ++,30%
              J10
              		 100 71 M Stomach Mucinous adenocarcinoma * T3N0M0 IIA Malignant 4.0*3.5*0.5 +,10% ++,70%
              K1
              		 101 56 F Stomach Adjacent normal stomach tissue (moderate inflammation) * * * NAT * - +,60%
              K2
              		 102 60 M Stomach Adjacent normal stomach tissue (mild inflammation) * * * NAT * - ++,80%
              K3
              		 103 49 F Stomach Adjacent normal stomach tissue (mild inflammation) * * * NAT * +,5% ++,80%
              K4
              		 104 53 M Stomach Adjacent normal stomach tissue (moderate inflammation) * * * NAT * +,6% ++,80%
              K5
              		 105 67 M Stomach Adjacent normal stomach tissue (moderate inflammation) * * * NAT * +,8% *
              K6
              		 106 63 M Stomach Adjacent normal stomach tissue (mild inflammation) * * * NAT * - ++,70%
              K7
              		 107 61 M Stomach Adjacent normal stomach tissue (mild inflammation) * * * NAT * - ++,80%
              K8
              		 108 70 M Stomach Adjacent normal stomach tissue (moderate inflammation) * * * NAT * +,10% ++,70%
              K9
              		 109 55 M Stomach Adjacent normal stomach tissue (mild inflammation) * * * NAT * +,3% ++,95%
              K10
              		 110 47 F Stomach Adjacent normal stomach tissue (mild inflammation) * * * NAT * - ++,70%
              _marker_
              Find overlapping cases with this tissue array:
              • DST1101
                File Format: .xlsx
                Release Date: 2025-01-17 15:56:36
                Download
              ArraysBank has pioneering biotechnology in healthcare
              Contact us
              +8888996266

              Technical Support: Info@biocoreusa.com

              Customer Service: Customerservices@biocoreusa.co

              Subscribe to our newsletter andstay up to date with our latest
              Follow us
              Copyright @BioCoreUSA Co,.Ltd.All Rights Reserved.
              1.218476s